Alzamend Neuro Inc. (ALZN)
NASDAQ: ALZN
· Real-Time Price · USD
3.64
0.08 (2.25%)
At close: May 23, 2025, 3:56 PM
3.65
0.32%
After-hours: May 23, 2025, 05:45 PM EDT
2.25% (1D)
| Bid | 3.45 |
| Market Cap | 2.91M |
| Revenue (ttm) | 76.11K |
| Net Income (ttm) | -4.23M |
| EPS (ttm) | -1210.59 |
| PE Ratio (ttm) | n/a |
| Forward PE | -0.32 |
| Analyst | Buy |
| Ask | 3.65 |
| Volume | 33,655 |
| Avg. Volume (20D) | 125,929 |
| Open | 3.61 |
| Previous Close | 3.56 |
| Day's Range | 3.48 - 3.65 |
| 52-Week Range | 3.06 - 135.54 |
| Beta | -0.17 |
About ALZN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ALZN
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ALZN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 week ago
-18.83%
ALZN stock has given up its prior gain. Alzamend N...
Unlock content with
Pro Subscription
1 week ago
-18.83%
Alzamend Neuro shares are trading higher after the company announced it initiated the Phase 2 clinical trial of AL001.
